drugset / Trial / NCT00333125

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

NCT00333125

Phase 3 Completed 319 enrolled Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the intraocular pressure (IOP)-lowering efficacy and safety of two combination products in patients with open-angle glaucoma or ocular hypertension.

Timeline

Start
2006-04
Primary completion
2007-02
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dorzolamide Small molecule 20 mg/ml Other
Comparator Timolol Other / unclassified 5 mg/ml Other
Subject Travoprost Other / unclassified 40 ug/ml Other